Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NICARDIPINE vs NINTEDANIB ESYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NICARDIPINE vs NINTEDANIB ESYLATE: Safety Overview

Metric NICARDIPINE NINTEDANIB ESYLATE
Total FAERS Reports 2,317 117
Deaths Reported 182 23
Death Rate 7.9% 19.7%
Hospitalizations 1,073 39
Average Patient Age 56.7 yrs 66.4 yrs
% Female Patients 60.8% 47.8%
FDA Approval Date Apr 10, 2024 Oct 15, 2014
Manufacturer Amici Pharma Inc Boehringer Ingelheim Pharmaceuticals,...
Route ORAL ORAL
Marketing Status Discontinued Prescription